Renate Schottmann

P394: INSIGHTS INTO PATIENT-DERIVED XENOGRAFT MODELS FOR DEK-NUP214 LEUKEMIA

Fiorella Charles Cano, Arnold Kloos, Thomas Fangmann, Nadine Kattre et autres

de (code pays fourni par la source)

Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia

Arnold Kloos, Konstantinos Mintzas, Lina Winckler, Razif Gabdoulline et autres

de, us, ca (code pays fourni par la source)

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia

Sagarajit Mohanty, Nidhi Jyotsana, Amit Sharma, Arnold Kloos et autres

de, us, in, at, ca (code pays fourni par la source)

Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia

Arnold Kloos, Konstantinos Mintzas, Lina Winckler, Razif Gabdoulline et autres

de, us, ca (code pays fourni par la source)

Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia

Anuhar Chaturvedi, Charu Gupta, Razif Gabdoulline, Nora Borchert et autres

de, us (code pays fourni par la source)

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in AML

Sagarajit Mohanty, Nidhi Jyotsana, Amit Sharma, Basem Othman et autres

de, ca (code pays fourni par la source)

Efficacy of Chemotherapy, Phd-Inhibitor Molidustat or BRD4 Inhibitor JQ1 in Combination with Targeted Inhibition of Mutated IDH1 in Human AML In Vivo

Anuhar Chaturvedi, Charu Gupta, Stefan Kaulfuß, Basem Othman et autres

de, us (code pays fourni par la source)

In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site

Anuhar Chaturvedi, Ramya Goparaju, Charu Gupta, Julia Weder et autres

de, nl (code pays fourni par la source)

Crystal structure of IDH1 R132H in complex with HMS101

Atul Chaturvedi, Ramya Goparaju, Chitrak Gupta, T. Kluenemann et autres

Functional Screening for Pathways Regulating Chemoresistance and Sensitivity in Leukemia Stem Cells

Konstantinos Mintzas, Arnold Kloos, Razif Gabdoulline, Renate Schottmann et autres

de (code pays fourni par la source)

Signaling Pathways of Mutant IDH1 Independent of R-2-Hydroxyglutarate

Charu Gupta, Michelle Cruz, Nidhi Jyotsana, Amit Sharma et autres

de, nl (code pays fourni par la source)

Prolyl Hydroxylase 3 (Phd3) Is a Therapeutic Target in Isocitrate Dehydrogenase 1 (IDH1) Mutated Acute Myeloid Leukemia

Anuhar Chaturvedi, Michelle Cruz, Ramya Goparaju, Razif Gabdoulline et autres

de, be (code pays fourni par la source)